Literature DB >> 22136461

Cardiovascular importance of the microRNA-23/27/24 family.

Claudia Bang1, Jan Fiedler, Thomas Thum.   

Abstract

MicroRNAs (miRNAs) are a class of highly conserved, noncoding short RNA molecules that regulate gene expression on the post-transcriptional level. MiRNAs are involved in a variety of processes such as proliferation, differentiation, and apoptosis. Deregulated expression of miRNAs has been linked to the development of diseases including cardiovascular disorders. Recently, the miR-23/27/24 cluster has been shown to be involved in angiogenesis and endothelial apoptosis in cardiac ischemia and retinal vascular development. In the present review, we summarize and discuss the role and importance of the miRNA-23/27/24 cluster during cardiovascular angiogenesis. Moreover, we illustrate a novel therapeutic application of the miRNA-23/27/24 cluster in vascular disorders and ischemic heart disease.
© 2012 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22136461     DOI: 10.1111/j.1549-8719.2011.00153.x

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  46 in total

1.  MicroRNA-24 antagonism prevents renal ischemia reperfusion injury.

Authors:  Johan M Lorenzen; Tamas Kaucsar; Celina Schauerte; Roland Schmitt; Song Rong; Anika Hübner; Kristian Scherf; Jan Fiedler; Filippo Martino; Regalla Kumarswamy; Malte Kölling; Inga Sörensen; Hebke Hinz; Joerg Heineke; Eva van Rooij; Hermann Haller; Thomas Thum
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

Review 2.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 3.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 4.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Authors:  Yu Zhang; Xinghui Sun; Basak Icli; Mark W Feinberg
Journal:  Endocr Rev       Date:  2017-04-01       Impact factor: 19.871

Review 5.  Vascular and circulating microRNAs in renal ischaemia-reperfusion injury.

Authors:  Johan M Lorenzen
Journal:  J Physiol       Date:  2015-03-31       Impact factor: 5.182

6.  MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling.

Authors:  Basak Icli; A K M Wara; Javid Moslehi; Xinghui Sun; Eva Plovie; Meghan Cahill; Julio F Marchini; Andrew Schissler; Robert F Padera; Jianru Shi; Hui-Wen Cheng; Srilatha Raghuram; Zoltan Arany; Ronglih Liao; Kevin Croce; Calum MacRae; Mark W Feinberg
Journal:  Circ Res       Date:  2013-09-18       Impact factor: 17.367

Review 7.  MicroRNAs in endothelial cell homeostasis and vascular disease.

Authors:  Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

Review 8.  MicroRNAs as pharmacological targets in endothelial cell function and dysfunction.

Authors:  Aránzazu Chamorro-Jorganes; Elisa Araldi; Yajaira Suárez
Journal:  Pharmacol Res       Date:  2013-04-18       Impact factor: 7.658

Review 9.  MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

Authors:  Eva van Rooij; Eric N Olson
Journal:  Nat Rev Drug Discov       Date:  2012-10-19       Impact factor: 84.694

10.  Embryonic atrazine exposure alters zebrafish and human miRNAs associated with angiogenesis, cancer, and neurodevelopment.

Authors:  Sara E Wirbisky; Gregory J Weber; Kelly E Schlotman; Maria S Sepúlveda; Jennifer L Freeman
Journal:  Food Chem Toxicol       Date:  2016-04-01       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.